Epidiolex is a 100 mg/ml oral solution plant-based, prescription cannabinoid-based medicine. It has been approved for use in the UK in three conditions. In July 2019, it was approved by the ...

UK-based GW Pharmaceuticals’ Epidiolex looks on course for approval in the US, after a panel of FDA experts unanimously backed it as a treatment for two rare forms of epilepsy. The FDA's ...